|
AREDS2 DNA Detail
|
|
|
| Records Return:
(53)
|
|
|
|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0165 | ED148635 | General Research Use | No | Male | White | 71 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0290 | ED148747 | General Research Use | No | Male | White | 78 | 10 - Central GA | 10 - Central GA |
| AR2_0685 | ED149554 | General Research Use | No | Female | White | 68 | 10 - Central GA | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2069 | ED148728 | General Research Use | No | Male | White | 82 | 10 - Central GA | 10 - Central GA |
| AR2_1453 | ED149442 | General Research Use | No | Female | White | 69 | 10 - Central GA | 10 - Central GA |
| AR2_2461 | ED149780 | General Research Use | No | Male | White | 82 | 10 - Central GA | 10 - Central GA |
| AR2_1346 | ED149500 | General Research Use | No | Male | White | 73 | 10 - Central GA | 10 - Central GA |
| AR2_1573 | ED148710 | General Research Use | No | Female | White | 75 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0795 | ED149267 | General Research Use | No | Male | White | 75 | 10 - Central GA | 10 - Central GA |
| AR2_2357 | ED148560 | General Research Use | No | Female | White | 75 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3906 | ED149613 | General Research Use | No | Male | White | 73 | 10 - Central GA | 10 - Central GA |
| AR2_4032 | ED149397 | General Research Use | No | Male | White | 66 | 10 - Central GA | 10 - Central GA |
| AR2_1195 | ED148252 | General Research Use | No | Female | White | 80 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2180 | ED149349 | General Research Use | No | Male | White | 55 | 10 - Central GA | 10 - Central GA |
| AR2_2223 | ED148475 | General Research Use | No | Male | White | 70 | 10 - Central GA | 10 - Central GA |
| AR2_2295 | ED149831 | General Research Use | No | Female | White | 71 | 10 - Central GA | 10 - Central GA |
| AR2_0352 | ED149153 | General Research Use | No | Female | White | 79 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1776 | ED149637 | General Research Use | No | Female | White | 63 | 10 - Central GA | 10 - Central GA |
| AR2_3031 | ED148733 | General Research Use | No | Male | White | 61 | 10 - Central GA | 10 - Central GA |
| AR2_3172 | ED149628 | General Research Use | No | Female | White | 51 | 10 - Central GA | 10 - Central GA |
|
|
|
|